Aspect Imaging developed its permanent-magnet compact MRI systems for market segments that conventional superconducting clinical MRI simply cannot serve: preclinical research imaging, industrial inspection, and small-animal veterinary imaging where a full-bore superconducting magnet is neither necessary nor practical. The company's M-Series platforms and related products use self-shielded permanent magnets that require no cryogens, no chiller, and minimal specialized infrastructure, opening deployment contexts that are closed to conventional high-field systems.
Financing an Aspect Imaging system is a different conversation than financing a clinical superconducting MRI installation. The acquisition cost is lower, the siting requirements are modest, and the intended use case is typically narrower and more specific than a general-purpose clinical MRI. We approach these transactions with underwriting calibrated to the actual use case, whether that is a preclinical research program at an academic institution, a veterinary specialty hospital adding diagnostic MRI capability, or an industrial applications context where MRI is used for non-destructive testing.
For veterinary practices in particular, the Aspect Imaging platform provides an accessible path to in-house MRI diagnostics for small animal work. Our page on veterinary MRI financing covers the full landscape of options for veterinary MRI acquisition, including where Aspect Imaging fits within that market. For research institutions, our research lab imaging financing page covers the specific considerations for research-context MRI funding.
Aspect Imaging Systems: Compact Permanent Magnet MRI
Aspect Imaging's M-Series platforms operate at field strengths in the range of 1T using compact permanent magnet designs. The self-contained, self-shielded architecture is the key engineering achievement: the system contains its own magnetic field without requiring the room-level RF shielding needed for superconducting systems. This allows installation in standard laboratory or clinical spaces with far fewer infrastructure requirements than conventional MRI.
The small bore diameter of Aspect Imaging systems, typically in the range of 16 to 26 centimeters depending on the model, defines their clinical scope. These bore dimensions are appropriate for small animals, including rats and mice in preclinical research settings, and small dogs and cats in veterinary diagnostic applications. They are not suitable for human clinical imaging, which places Aspect Imaging firmly in the preclinical, veterinary, and specialty research markets.
The practical advantages of the compact permanent magnet design are real for the right buyer. Installation can occur in an existing room without major construction. The systems do not require liquid helium or any cryogenic management. Power consumption is low compared to superconducting MRI. Ongoing operating costs are therefore substantially lower than for a full superconducting clinical system. For a university research lab running long-term animal studies, the total cost of ownership over a five-year research grant period looks very different for an Aspect Imaging system than for a conventional preclinical MRI platform.
Who Finances Aspect Imaging Systems
Academic research institutions and pharmaceutical research facilities that perform preclinical imaging as part of drug development, neuroscience research, or oncology model work are the primary buyers of Aspect Imaging platforms in the research context. These acquisitions are often funded through grant capital or institutional research budgets, but equipment financing can supplement grant funding or bridge the timing between grant approval and fund availability. Our research lab imaging program handles the documentation structures common to academic and research-context transactions.
Veterinary specialty hospitals and referral practices that want in-house MRI for small animal neurology, orthopedics, and oncology assessment are a natural fit for the Aspect Imaging compact systems. A small animal hospital that currently refers patients to a human MRI facility for after-hours scanning, or that sends patients to a veterinary specialty center with MRI, can evaluate an in-house Aspect Imaging system against the cost of those referrals and the clinical benefit of in-house diagnostic capability. Our veterinary hospital MRI financing page covers this buyer category in detail.
Industrial MRI users, including manufacturers that use MRI for non-destructive testing, food inspection, or material characterization, represent a third buyer category. These transactions are commercial equipment financing in a non-medical context, and the underwriting approach reflects the industrial rather than clinical use case. We handle these as standard commercial equipment loans when the application falls within our transaction scope.
Structuring Aspect Imaging MRI Financing
Aspect Imaging transactions typically fall in a price range that qualifies entirely within our application-only program. The streamlined credit review requires a completed application and vendor documentation without a full financial package for most buyers in this price range. For academic institutions with research-specific procurement requirements, the documentation may differ from commercial purchases, and we adapt the process accordingly.
We structure equipment loans with terms from 24 to 60 months for Aspect Imaging systems. The lower acquisition price supports shorter term options that keep total interest cost minimal for buyers who can service a higher monthly payment. For buyers who need to match the loan term to a research grant period, we can structure terms to align with the grant's performance period.
For veterinary practices, the underwriting is similar to any equipment financing for a veterinary business: we look at the practice's revenue history, client base, and the projected additional revenue from in-house MRI capability against the proposed monthly debt service. The math on this model often works well because veterinary specialty practices that currently refer clients out for MRI can capture that revenue directly.
Total Cost of Ownership: Why Aspect Imaging Can Win the Model
The total cost of ownership argument for a compact permanent-magnet MRI system like Aspect Imaging is compelling for the right buyer. A superconducting preclinical MRI system requires cryogen management, a dedicated magnet room with full RF shielding, specialized power infrastructure, and a service contract that reflects the complexity of a cryogenic system. These ongoing costs add substantially to the initial acquisition price over a five- to ten-year operating period.
An Aspect Imaging system in a well-configured installation has lower ongoing costs across most of these categories. The absence of cryogen management eliminates one of the most variable and potentially expensive ongoing costs of a superconducting system. Reduced shielding requirements lower the initial installation cost. Lower power consumption reduces operating overhead. For a research lab evaluating equipment over the life of a multi-year grant, the total-cost argument can favor the compact permanent-magnet system even if its upfront price is not dramatically lower than a superconducting alternative at the same bore size.
Tax treatment through Section 179 expensing applies to Aspect Imaging systems purchased for business or research use in the appropriate entity structures, and the typically lower acquisition cost means the full purchase price often falls well within the annual Section 179 limit.
Aspect Imaging MRI Financing Questions
- Can a university research program finance an Aspect Imaging system through an equipment loan rather than purchasing outright? Yes, though the legal entity and procurement authority matter for academic institutions. Research foundations, university entities, and affiliated companies that procure equipment as commercial borrowers can access standard equipment financing. Public university procurement may have specific requirements that affect structure.
- Is Aspect Imaging still actively manufacturing and supporting its systems? Aspect Imaging has operated as a company in the compact permanent-magnet MRI space. Buyers should verify current product availability, warranty terms, and service support directly with Aspect Imaging or authorized distributors as part of due diligence before purchase. We assess service support availability as part of our collateral review.
- Can the Aspect Imaging system be used for human clinical imaging? The compact bore sizes of Aspect Imaging systems are not suitable for human clinical imaging. These systems are designed for preclinical, veterinary, and industrial applications. For human clinical MRI financing, see our pages on low-field clinical MRI options.
- We are a small biotech company that wants an in-house Aspect Imaging system for drug development work. Are we eligible? Small biotechs and pharmaceutical research companies are eligible for commercial equipment financing. The underwriting looks at the company's financial position, runway, and the proposed use of the system. Early-stage companies may face more scrutiny but can qualify with appropriate documentation.
Finance Your Aspect Imaging Compact MRI System
If your research program, veterinary practice, or industrial application has identified an Aspect Imaging system as the right tool, send us the acquisition details. We handle preclinical, veterinary, and specialty MRI financing across a range of institutional and commercial borrower types. Most Aspect Imaging transactions fall within our application-only range and can close efficiently once a complete package is received.